Mereo BioPharma MREO
NASDAQ MREO
$0.31 +0.01 (+2.92%)
At close: Nov 11, 2026 · 4:00 PM EST

Mereo BioPharma (MREO) Revenue (2023 - 2026)

Updated

Mereo BioPharma's Revenue was $500,000 in FY2025.

Analysis

Mereo BioPharma (MREO) Revenue (2023 - 2026) Analysis & Trends

  • Revenue shows a four-year compound annual growth rate of -68.2% (FY2021 to FY2025).
  • Per Business Quant data, Revenue in earlier years was $10 million in FY2023 and $49.15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Mereo BioPharma 47.91 Mn -79.40 Mn 800,000.00 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 800,000.00
Mar 31, 2026 11,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 -180,000.00
Dec 31, 2023 1.00 Mn
Jun 30, 2023 9.00 Mn
API Access

Mereo BioPharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=MREO&period=max&api_key=YOUR_API_KEY